Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Cost of Revenue: 2019-2024

Historic Cost of Revenue for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to $319,108.

  • Mainz Biomed N.V's Cost of Revenue fell 49.02% to $80,027 in Q4 2023 from the same period last year, while for Dec 2023 it was $385,820, marking a year-over-year increase of 10.96%. This contributed to the annual value of $319,108 for FY2024, which is 17.29% down from last year.
  • Mainz Biomed N.V's Cost of Revenue amounted to $319,108 in FY2024, which was down 17.29% from $385,820 recorded in FY2023.
  • In the past 5 years, Mainz Biomed N.V's Cost of Revenue registered a high of $399,726 during FY2021, and its lowest value of $319,108 during FY2024.
  • Moreover, its 3-year median value for Cost of Revenue was $347,726 (2022), whereas its average is $350,885.
  • In the last 5 years, Mainz Biomed N.V's Cost of Revenue grew by 10.96% in 2023 and then declined by 17.29% in 2024.
  • Over the past 5 years, Mainz Biomed N.V's Cost of Revenue (Yearly) stood at $370,480 in 2020, then increased by 7.89% to $399,726 in 2021, then dropped by 13.01% to $347,726 in 2022, then increased by 10.96% to $385,820 in 2023, then decreased by 17.29% to $319,108 in 2024.